Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
Sinopharm Group Co ( (HK:1099) ) has issued an update.
Sinopharm Group Co. Ltd. announced the resignation of Mr. Sun Jinglin as an executive director and member of the strategy and investment committee, effective immediately. Mr. Sun’s departure is amicable, with no disagreements reported. The board expressed gratitude for his contributions to the company’s development. Concurrently, the board proposed the appointment of Mr. Yang Binghua as a new executive director, subject to shareholder approval. Mr. Yang, with a strong background in public administration and experience in significant roles within state-owned enterprises, is expected to contribute to the company’s strategic direction. His appointment will be finalized upon approval at the general meeting, and his remuneration will be performance-based.
The most recent analyst rating on (HK:1099) stock is a Buy with a HK$21.00 price target. To see the full list of analyst forecasts on Sinopharm Group Co stock, see the HK:1099 Stock Forecast page.
More about Sinopharm Group Co
Sinopharm Group Co. Ltd. is a company registered as a non-Hong Kong entity under the Hong Kong Companies Ordinance. It is involved in the pharmaceutical industry, focusing on sustainable and stable development and continuous improvement of corporate governance.
Average Trading Volume: 5,306,221
Technical Sentiment Signal: Strong Buy
Current Market Cap: HK$60.53B
Find detailed analytics on 1099 stock on TipRanks’ Stock Analysis page.